Last10K.com

Pharmabio Serv, Inc. (PBSV) SEC Filing 10-K Annual Report for the fiscal year ending Monday, October 31, 2022

SEC Filings

PBSV Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

PBSV Annual Reports

PBSV Quarterly Reports

PBSV Corporate News

Pharmabio Serv, Inc.

HISTORY TOOLS
CIK: 1304161 Ticker: PBSV
Cover - USD ($)
12 Months Ended
Oct. 31, 2022
Jan. 25, 2023
Apr. 30, 2022
Cover [Abstract]   
Entity Registrant NamePHARMA-BIO SERV, INC.  
Entity Central Index Key0001304161  
Document Type10-K  
Amendment Flagfalse  
Entity Voluntary FilersNo  
Current Fiscal Year End Date--10-31  
Entity Well Known Seasoned IssuerNo  
Entity Small Businesstrue  
Entity Shell Companyfalse  
Entity Emerging Growth Companyfalse  
Entity Current Reporting StatusYes  
Document Period End DateOct. 31, 2022  
Entity Filer CategoryNon-accelerated Filer  
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2022  
Entity Common Stock Shares Outstanding 22,950,321 
Entity Public Float  $ 12,340,595
Document Annual Reporttrue  
Document Transition Reportfalse  
Entity File Number000-50956  
Entity Incorporation State Country CodeDE  
Entity Tax Identification Number20-0653570  
Entity Interactive Data CurrentYes  
Icfr Auditor Attestation Flagfalse  
Entity Address City Or TownDorado  
Entity Address CountryPR  
Entity Address Postal Zip Code00646  
City Area Code787  
Local Phone Number278-2709  
Entity Address Address Line 1Pharma-Bio Serv Building,#6 Road 696  
Auditor Firm Id871  
Auditor NameCROWE PR PSC  
Auditor LocationGuaynabo, Puerto Rico  

View differences made from one year to another to evaluate Pharmabio Serv, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Pharmabio Serv, Inc..

Continue

Assess how Pharmabio Serv, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Pharmabio Serv, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' Equity
Consolidated Statements Of Comprehensive Income
Consolidated Statements Of Operations
Concentration Of Risks (Details Narrative)
Concentrations Of Risks
Contingencies
Customer Account Receivable
Customer Account Receivable (Details Narrative)
Earnings (Loss) Per Share
Earnings (Loss) Per Share (Tables)
Earnings Per Share (Details Narrative)
Earnings Per Share (Details)
Equity Transactions
Equity Transactions (Details Narrative)
Income Taxes
Income Taxes (Details Narrative)
Income Taxes (Details)
Income Taxes (Tables)
Leases
Leases (Details Narrative)
Leases (Details)
Leases (Tables)
Loans Forgiveness
Loans Forgiveness (Details Narrative)
Organization And Summary Of Significant Accounting Policies
Organization And Summary Of Significant Accounting Policies (Policies)
Property And Equipment
Property And Equipment (Details)
Property And Equipment (Tables)
Related Party Transactions
Related Party Transactions (Details Narrative)
Retirement Plan
Retirement Plan (Details Narrative)
Segment Disclosures
Segment Disclosures (Details)
Segment Disclosures (Tables)
Stock Options And Stock Based Compensation
Stock Options And Stock Based Compensation (Details 1)
Stock Options And Stock Based Compensation (Details 2)
Stock Options And Stock Based Compensation (Details Narrative)
Stock Options And Stock Based Compensation (Details)
Stock Options And Stock Based Compensation (Tables)

Material Contracts, Statements, Certifications & more

Pharmabio Serv, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 21.1: List Of Subsidiaries
Exhibit 23.1: Consent Of Crowe Pr Psc
Exhibit 31.1: Certification
Exhibit 31.2: Certification
Exhibit 32.1: Certification
Ticker: PBSV
CIK: 1304161
Form Type: 10-K Annual Report
Accession Number: 0001654954-23-001018
Submitted to the SEC: Mon Jan 30 2023 4:57:50 PM EST
Accepted by the SEC: Mon Jan 30 2023
Period: Monday, October 31, 2022
Industry: Management Consulting Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/pbsv/0001654954-23-001018.htm